{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:05:46Z","timestamp":1791986746207,"version":"4.4.0"},"reference-count":35,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2022,3,30]]},"DOI":"10.1536\/ihj.21-790","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T22:24:49Z","timestamp":1648592689000},"page":"338-346","source":"Crossref","is-referenced-by-count":9,"title":["Functional Evaluation of Human Bioengineered Cardiac Tissue Using iPS Cells Derived from a Patient with Lamin Variant Dilated Cardiomyopathy"],"prefix":"10.1536","volume":"63","author":[{"given":"Koichiro","family":"Miura","sequence":"first","affiliation":[{"name":"Institute of Advanced Biomedical Engineering and Science, Tokyo Women&apos;s Medical University"},{"name":"Department of Cardiology, Tokyo Women&apos;s Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhisa","family":"Matsuura","sequence":"additional","affiliation":[{"name":"Institute of Advanced Biomedical Engineering and Science, Tokyo Women&apos;s Medical University"},{"name":"Department of Cardiology, Tokyo Women&apos;s Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yamasaki Itoyama","sequence":"additional","affiliation":[{"name":"Institute of Advanced Biomedical Engineering and Science, Tokyo Women&apos;s Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Institute of Advanced Biomedical Engineering and Science, Tokyo Women&apos;s Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Takada","sequence":"additional","affiliation":[{"name":"Institute of Advanced Biomedical Engineering and Science, Tokyo Women&apos;s Medical University"},{"name":"Department of Cardiology, Tokyo Women&apos;s Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Furutani","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology and Adult Congenital Cardiology, Tokyo Women&apos;s Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiko","family":"Hayama","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology and Adult Congenital Cardiology, Tokyo Women&apos;s Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamichi","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seitaro","family":"Nomura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Toyoda","sequence":"additional","affiliation":[{"name":"Center for Regenerative Medicine, National Center for Child Health and Development Research Institute"},{"name":"Tokyo Metropolitan Institute of Gerontology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Umezawa","sequence":"additional","affiliation":[{"name":"Center for Regenerative Medicine, National Center for Child Health and Development Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Onoue","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nara Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nara Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Aburatani","sequence":"additional","affiliation":[{"name":"Research Center for Advanced Science and Technology, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Nakanishi","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology and Adult Congenital Cardiology, Tokyo Women&apos;s Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhisa","family":"Hagiwara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Women&apos;s Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issei","family":"Komuro","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Institute of Advanced Biomedical Engineering and Science, Tokyo Women&apos;s Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","unstructured":"1. Haas J, Frese KS, Peil B, <i>et al<\/i>. Atlas of the clinical genetics of human dilated cardiomyopathy. Eur Heart J 2015; 36: 1123-1135a."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Tobita T, Nomura S, Fujita T, <i>et al<\/i>. Genetic basis of cardiomyopathy and the genotypes involved in prognosis and left ventricular reverse remodeling. Sci Rep 2018; 8: 1998.","DOI":"10.1038\/s41598-018-20114-9"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Merlo M, Pyxaras SA, Pinamonti B, <i>et al<\/i>. Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. J Am Coll Cardiol 2011; 57: 1468-76.","DOI":"10.1016\/j.jacc.2010.11.030"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Matsumura Y, Hoshikawa-Nagai E, Kubo T, <i>et al<\/i>. Left ventricular reverse remodeling in long-term (&gt;12 years) survivors with idiopathic dilated cardiomyopathy. Am J Cardiol 2013; 111: 106-10.","DOI":"10.1016\/j.amjcard.2012.08.056"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Matsuura K, Utoh R, Nagase K, <i>et al<\/i>. Cell sheet approach for tissue engineering and regenerative medicine. J Control Release 2014; 190: 228-39.","DOI":"10.1016\/j.jconrel.2014.05.024"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Matsuura K, Wada M, Shimizu T, <i>et al<\/i>. Creation of human cardiac cell sheets using pluripotent stem cells. Biochem Biophys Res Commun 2012; 425: 321-7.","DOI":"10.1016\/j.bbrc.2012.07.089"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Matsuura K, Seta H, Haraguchi Y, <i>et al<\/i>. <i>TRPV-1<\/i>-mediated elimination of residual iPS cells in bioengineered cardiac cell sheet tissues. Sci Rep 2016; 6: 21747.","DOI":"10.1038\/srep21747"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Sasaki D, Matsuura K, Seta H, <i>et al<\/i>. Contractile force measurement of human induced pluripotent stem cell-derived cardiac cell sheet-tissue. PLOS ONE 2018; 13: e0198026.","DOI":"10.1371\/journal.pone.0198026"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Yamasaki Y, Matsuura K, Sasaki D, <i>et al<\/i>. Assessment of human bioengineered cardiac tissue function in hypoxic and re-oxygenized environments to understand functional recovery in heart failure. Regen Ther 2021; 18: 66-75.","DOI":"10.1016\/j.reth.2021.03.007"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Okita K, Yamakawa T, Matsumura Y, <i>et al<\/i>. An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells 2013; 31: 458-66.","DOI":"10.1002\/stem.1293"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Seta H, Matsuura K, Sekine H, <i>et al<\/i>. Tubular cardiac tissues derived from human induced pluripotent stem cells generate pulse pressure in vivo. Sci Rep 2017; 7: 45499.","DOI":"10.1038\/srep45499"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Clements M, Thomas N. High-throughput multi-parameter profiling of electrophysiological drug effects in human embryonic stem cell derived cardiomyocytes using multi-electrode arrays. Toxicol Sci 2014; 140: 445-61.","DOI":"10.1093\/toxsci\/kfu084"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Fukawatase Y, Toyoda M, Okamura K, <i>et al<\/i>. Ataxia telangiectasia derived iPS cells show preserved x-ray sensitivity and decreased chromosomal instability. Sci Rep 2014; 4: 5421.","DOI":"10.1038\/srep05421"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Nishino K, Toyoda M, Yamazaki-Inoue M, <i>et al<\/i>. DNA methylation dynamics in human induced pluripotent stem cells over time. PLoS Genet 2011; 7: e1002085.","DOI":"10.1371\/journal.pgen.1002085"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Matsuura K, Masuda S, Haraguchi Y, <i>et al<\/i>. Creation of mouse embryonic stem cell-derived cardiac cell sheets. Biomaterials 2011; 32: 7355-62.","DOI":"10.1016\/j.biomaterials.2011.05.042"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Maron BJ, Towbin JA, Thiene G, <i>et al<\/i>. Contemporary definitions and classification of the cardiomyopathies: An American Heart Association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation 2006; 113: 1807-16.","DOI":"10.1161\/CIRCULATIONAHA.106.174287"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Hershberger RE, Hedges DJ, Morales A. Dilated cardiomyopathy: The complexity of a diverse genetic architecture. Nat Rev Cardiol 2013; 10: 531-47.","DOI":"10.1038\/nrcardio.2013.105"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Onoue K, Wakimoto H, Jiang J, <i>et al<\/i>. Cardiomyocyte proliferative capacity is restricted in mice with LMNA mutation. Front Cardiovasc Med 2021; 8: 639148.","DOI":"10.3389\/fcvm.2021.639148"},{"key":"19","unstructured":"19. lmeida DR, <i>et al<\/i>. Left atrial volume determinants in patients with non-ischemic dilated cardiomyopathy. Arq Bras Cardiol 2015; 105: 65-70."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Sabatino J, Di Salvo G, Prota C, <i>et al<\/i>. Left atrial strain to identify diastolic dysfunction in children with cardiomyopathies. J Clin Med 2019; 8.","DOI":"10.3390\/jcm8081243"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Schultheiss HP, Fairweather D, Caforio ALP, <i>et al<\/i>. Dilated cardiomyopathy. Nat Rev Dis Primers 2019; 5: 32.","DOI":"10.1038\/s41572-019-0084-1"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Anderson DJ, Kaplan DI, Bell KM, <i>et al<\/i>. NKX2-5 regulates human cardiomyogenesis via a <i>HEY2<\/i> dependent transcriptional network. Nat Commun 2018; 9: 1373.","DOI":"10.1038\/s41467-018-03714-x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Garg V, Kathiriya IS, Barnes R, <i>et al<\/i>. <i>GATA4<\/i> mutations cause human congenital heart defects and reveal an interaction with <i>TBX5<\/i>. Nature 2003; 424: 443-7.","DOI":"10.1038\/nature01827"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Qiao XH, Wang F, Zhang XL, <i>et al<\/i>. <i>MEF2C<\/i> loss-of-function mutation contributes to congenital heart defects. Int J Med Sci 2017; 14: 1143-53.","DOI":"10.7150\/ijms.21353"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ang YS, Rivas RN, Ribeiro AJS, <i>et al<\/i>. Disease model of <i>GATA4<\/i> mutation reveals transcription factor cooperativity in human cardiogenesis. Cell 2016; 167: 1734-1749.e22.","DOI":"10.1016\/j.cell.2016.11.033"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Huang WY, Cukerman E, Liew CC. Identification of a GATA motif in the cardiac alpha-myosin heavy-chain-encoding gene and isolation of a human <i>GATA-4<\/i> cDNA. Gene 1995; 155: 219-23.","DOI":"10.1016\/0378-1119(94)00893-W"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Skerjanc IS, Petropoulos H, Ridgeway AG, <i>et al<\/i>. Myocyte enhancer factor 2C and <i>NKX2-5<\/i> up-regulate each other&apos;s expression and initiate cardiomyogenesis in P19 cells. J Biol Chem 1998; 273: 34904-10.","DOI":"10.1074\/jbc.273.52.34904"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Vincentz JW, Barnes RM, Firulli BA, <i>et al<\/i>. Cooperative interaction of <i>NKX2.5<\/i> and <i>MEF2C<\/i> transcription factors during heart development. Dev Dyn 2008; 237: 3809-19.","DOI":"10.1002\/dvdy.21803"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Park WJ, Oh JG. SERCA2a: A prime target for modulation of cardiac contractility during heart failure. BMB Rep 2013; 46: 237-43.","DOI":"10.5483\/BMBRep.2013.46.5.077"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Lee J, Termglinchan V, Diecke S, <i>et al<\/i>. Activation of PDGF pathway links <i>LMNA<\/i> mutation to dilated cardiomyopathy. Nature 2019; 572: 335-40.","DOI":"10.1038\/s41586-019-1406-x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Bertero A, Fields PA, Smith AST, <i>et al<\/i>. Chromatin compartment dynamics in a haploinsufficient model of cardiac laminopathy. J Cell Biol 2019; 218: 2919-44.","DOI":"10.1083\/jcb.201902117"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32. Masuda S, Matsuura K, Shimizu T. Inhibition of <i>LYPD1<\/i> is critical for endothelial network formation in bioengineered tissue with human cardiac fibroblasts. Biomaterials 2018; 166: 109-21.","DOI":"10.1016\/j.biomaterials.2018.03.002"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Lachaize V, Pe\u00f1a B, Ciubotaru C, <i>et al<\/i>. Compromised biomechanical properties, cell-cell adhesion and nanotubes communication in cardiac fibroblasts carrying the lamin A\/C D192G mutation. Int J Mol Sci 2021; 22.","DOI":"10.3390\/ijms22179193"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Chen SN, Lombardi R, Karmouch J, <i>et al<\/i>. DNA damage response\/TP53 pathway is activated and contributes to the pathogenesis of dilated cardiomyopathy associated with lamin A\/C mutations. Circ Res 2019; 124: 856-73.","DOI":"10.1161\/CIRCRESAHA.118.314238"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Wolf CM, Wang L, Alcalai R, <i>et al<\/i>. Lamin A\/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease. J Mol Cell Cardiol 2008; 44: 293-303.","DOI":"10.1016\/j.yjmcc.2007.11.008"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/63\/2\/63_21-790\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:24:08Z","timestamp":1715232248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/63\/2\/63_21-790\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,30]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.21-790","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,30]]},"article-number":"21-790"}}